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Non-coding RNAs (ncRNAs) have emerged as critical regulators of transcription, epigenetic
processes, and gene silencing, which make them ideal candidates for insight into molec-
ular evolution and a better understanding of the molecular pathways of neuropsychiatric
disease. Here, we provide an overview of the current state of knowledge regarding various
classes of ncRNAs and their role in neural plasticity and cognitive function, and highlight the
potential contribution they may make to the development of a variety of neuropsychiatric
disorders, including schizophrenia, addiction, and fear-related anxiety disorders.
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INTRODUCTION
From whence we came, whither we go: the rise of the RNA world.
When Woese, Orgel, and Crick each wrote about the origin and
evolution of the genetic code they laid the foundation for “The
RNA world hypothesis,” which was later developed by Gilbert
(Woese, 1967; Crick, 1968; Orgel, 1968; Gilbert, 1986). This
hypothesis stemmed from the fact that ancient RNA had the abil-
ity to transmit heritable information as well as, in the case of
ribozymes, being endowed with enzymatic capacity (Cech et al.,
1981; Kruger et al., 1982; Guerrier-Takada et al., 1983; Joyce, 2002;
Cech, 2011). With the advent of next-generation sequencing tech-
nology, coordinated efforts such as the ENCODE and FANTOM
3 projects have revealed that more than 90% of the genome is
actively transcribed, whereas only ∼2% codes for functional pro-
tein. These landmark observations brought into question the true
value of RNA as a regulatory molecule and have since motivated
scientists to embark on a deeper exploration of the biological
function of so-called“junkDNA”or“genomic darkmatter”(John-
son et al., 2005; Derrien et al., 2011). Many non-coding RNAs
(ncRNAs) are highly conserved and correlate with the degree of
eukaryotic complexity, further strengthening the argument that
they are more than simple artifacts of evolution (Grifﬁths-Jones
et al., 2005; Taft et al., 2007; Heimberg et al., 2008; Mattick, 2011).
In fact, their ability to drive transcription, direct epigenetic pro-
cesses, and silence gene expression make ncRNAs ideal candidates
for insight into molecular evolution and a better understanding of
themolecular pathways of neuropsychiatric disease. In this review,
weprovide anoverviewof the current state of knowledge regarding
the involvement of various classes of ncRNAs in neural plasticity
as well as their potential role in a variety of neuropsychiatric disor-
ders, particularly those characterized by impairments in cognitive
function.
NON-CODING RNA: A KEY DRIVER OF GENE REGULATION
The broad potential of ncRNAs to critically regulate transcrip-
tion and translation has been appreciated for some time with the
discovery and characterization of various ncRNA families, the
majority of which have been shown to be capable of directing
epigenetic processes (Mattick and Makunin, 2006). A simplistic
division of the different classes of ncRNAs can be made based on
their size: small ncRNAs, between 20 and 200nt, and long ncRNAs,
arbitrarily identiﬁed as any ncRNA over 200 nt. Small ncRNAs
amazed the scientiﬁcworldwhen theywere identiﬁed as inCaenor-
habditis elegans as being involved in the post-transcriptional
regulation of genes during development (Lee et al., 1993; Wight-
man et al., 1993). Moreover, Fire and Mello were awarded a Nobel
prize in 2006 for their discovery of RNA interference in C. ele-
gans (Fire et al., 1998). Long ncRNAs have also recently entered
the spotlight. For example, Rinn et al. (2007) recently discovered
a long ncRNA called HOTAIR, which regulates epigenetic con-
trol over the HOXD locus, thereby providing novel evidence for a
functionally relevant role for this enigmatic family of non-coding
transcripts.
SMALL ncRNAs: miRNAs
MicroRNAs (miRNAs) are a class of endogenous, small ncRNAs
that mediate post-transcriptional gene silencing by complemen-
tary binding to the 3′-untranslated region (3′ UTR) of their target
mRNA, a key process for regulating gene expression in a tissue-
and developmental stage-speciﬁcmanner (Liu andKohane, 2009).
As illustrated in Figure 1A, the biogenesis of miRNAs begins in
the nucleus through a canonical pathway as a large primary-RNA
(pri-RNA) molecule, which folds into a stem loop transcribed
by both RNA polymerase II (RNA Pol II) and RNA polymerase
III (RNA Pol III; Kim, 2005; Borchert et al., 2006). This hairpin
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FIGURE 1 | (A) miRNA biogenesis begins in the nucleus where Drosha and
DGCR8 cleave the primary RNA resulting in a miRNA precursor that is
exported to the cytoplasm by Exportin5 and Ran-GTP61 where it is then
processed by Dicer andTRBP. Next, the mature miRNA duplex is incorporated
to the RISC where it is cleaved Dicer, associates with AGO2, and
subsequently binds to the 3′ UTR of a target RNA leading to either mRNA
degradation or translational repression. (B) Similarly, siRNA biogenesis
depends on Dicer activity and incorporation into the RISC, however siRNAs
avoid cleavage by Drosha as they are derived from exogenous viral or
endogenous double-stranded RNA molecules mostly within the cytoplasm.
Given the speciﬁcity of base pairing, the ﬁnal outcome of the siRNA
interference is the cleavage and degradation of their target mRNAs.
structure is then processed by an enzyme known as Drosha, which
works with the RNA-binding protein DGCR8 (DiGeorge critical
region 8, called Phasa in invertebrates; Kim, 2009) to produce
a ∼70 nt (precursor) pre-miRNA that is then shuttled to the
cytoplasm via Exportin5 and Ran-GTP61. The pre-miRNA is
cleaved in the cytoplasm by an enzyme called Dicer, together with
double-stranded RNA binding proteins (dsRBPs) including TRBP
(Yi et al., 2003). At this stage, a double-stranded mature miRNA
can be detected; however, its inhibitory capacity depends onDicer-
mediated incorporation of one of its strands, together with the
Argonaute (Ago) protein, into the RNA-induced silencing com-
plex (RISC; Chendrimada et al., 2005). The RISC then directs
the miRNA toward a complementary “seed” sequence within the
3′ UTR of its target mRNA (Wightman et al., 1993; Reinhart et al.,
2000; Pillai et al., 2005). The level of complementarity between the
miRNA and its target mRNA determines whether the mRNA is
degraded or translation is disrupted (Sakurai et al., 2011). Recent
ﬁndings suggest that these canonical processes have many vari-
ations (Volk and Shomron, 2011). For example, insertion at 5′
UTR and coding sequences has been shown to result in simi-
lar miRNA activity, and substrates for the formation of miRNA
can found be within intronic regions (mirtrons), directly spliced
by RNA Pol II, thereby eluding the activity of Drosha (Lee et al.,
2004; Ruby et al., 2007). Furthermore, they may also be derived
from small nucleolar RNAs, transfer RNAs or by tRNase Z activity
(Yang and Lai, 2011).
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MicroRNAs are predicted to affect up to 60% of protein-
coding transcripts (Lewis et al., 2005; Friedman et al., 2009), and
have been implicated in essential biological processes includ-
ing stem cell division particularly in mammalian development
(Hatﬁeld et al., 2005; Shcherbata et al., 2006; Qi et al., 2009), dif-
ferentiation and development (Reinhart et al., 2000; Foshay and
Gallicano, 2009; Xu et al., 2009; Liu et al., 2012; Zhang et al.,
2012b), as well as apoptosis and cancer (Wang et al., 2008b, 2009;
Kim, 2009; Corthals et al., 2011; Rissland et al., 2011; Sreekumar
et al., 2011; Nie et al., 2012; Yi et al., 2012). Recent investiga-
tions using Dicer knockout mice have also shown that miRNA
dysregulation leads to abnormalities in brain development and
neuronal stem cell differentiation (De Pietri Tonelli et al., 2008;
Huang et al., 2010; Kawase-Koga et al., 2010), increased cortical
neurodegeneration (Davis et al., 2008; Hebert et al., 2010), and
altered learning and memory (Konopka et al., 2010). Although
most miRNAs are expressed in the brain, their role in neurogen-
esis, synaptic plasticity, and cognitive function is only beginning
to be elucidated, and considerable work is required in order to
better understand their inﬂuence within the context of neuropsy-
chiatric disorders (Bredy et al., 2011; O’Connor et al., 2011). For
example, among an increasing number of miRNAs implicated in
schizophrenia, miR-132 is a CREB-regulated miRNA driven by
NMDA receptor signaling, which has been shown to be impor-
tant for cognitive processing and is dysregulated in the brains
of patients with the disorder (Kim et al., 2010; Moreau et al.,
2011; Miller et al., 2012). Furthermore,miR-219, another NMDA-
receptor-regulated miRNA, has been functionally linked to the
behavioral impairments associated with schizophrenia (Kocerha
et al., 2009). The progression of Alzheimer’s disease is character-
ized by cognitive decline and anxiety disorder related to dementia.
Recently, Zovoilis et al. (2011) identiﬁed miR-34c as a negative
regulator of memory consolidation in mice, with miR-34c also
markedly increased in the brains of patients with Alzheimer’s dis-
ease. Interestingly, around the same time, it was demonstrated that
the expression of miR-34c increases dramatically in response to
acute stress, thereby providing a potential link between miRNA
activity, cognitive function and anxiety in Alzheimer’s disease
(Haramati et al., 2011).
More recently, we reported a role for miRNAs in regulating
cognitive processes associated with fear-related anxiety disorder.
Fear-extinction learning in C57/Bl6J mice led to increased expres-
sion of the brain-speciﬁc miRNA, miR-128b, which disrupted
stability of several plasticity-related target genes and regulated for-
mation of fear-extinction memory. We proposed that increased
miR-128b activity might facilitate the transition from retrieval of
the original fear memory toward the formation of a new fear-
extinctionmemory, the disruptionof whichwould have important
implications for the development of fear-related anxiety disorder
(Lin et al., 2011).
MicroRNA-mediated regulation of gene function has also
been implicated in the development of addiction. The miRNAs
miR-124, Let-7d, and miR-181 are up-regulated in the nucleus
accumbens in response to cocaine, andknockdownof eachof these
miRNAs inﬂuences cocaine-seeking behavior (Chandrasekar and
Dreyer, 2009, 2011). Using an elegant dopamine cell type-speciﬁc
knockout approach, Schaefer et al. (2010) demonstrated thatAgo2,
a subunit of Argonaute, is critical for mediating the motiva-
tional aspects of cocaine self-administration. Importantly, there
are speciﬁc Ago2-dependent miRNAs that are cocaine-inducible,
including miR-181a, miR-324, and miR-369, which may therefore
be involved in this effect. Indeed, miR-324 and miR-369 reg-
ulate MEF2 and FosB, two plasticity-related genes required for
cognitive functioning associated with cocaine-seeking behavior
(Pulipparacharuvil et al., 2008; Renthal et al., 2009). As MEF2 has
been implicated in the suppression of excitatory synaptic density
(Flavell et al., 2006), a miRNA-mediated negative regulation of
MEF2 may remove this constraint and increase synaptogenesis in
response to cocaine-associated learning. Furthermore, miR-212
expression is increased in the striatum after extended access to
cocaine, and over-expression of this miRNA decreases cocaine-
seeking behavior (Hollander et al., 2010). Recently, it has been
demonstrated that the methyl CpG-binding protein 2 (MECP2)
mediates the escalation of reward-seeking behavior in rats through
a homeostatic interaction with miR-212 and subsequent regula-
tion of brain-derived neurotrophic factor (BDNF) in the striatum
(Im et al., 2010). This is a particularly interesting ﬁnding as it pro-
vides some of the ﬁrst evidence to suggest that ncRNA-directed
regulation of the epigenome occurs in an activity-dependent
manner in vivo.
SHORT INTERFERING RNAs
Very little is known about the role of short interfering RNAs
(siRNAs) in the context of neurodegenerative disease or neu-
ropsychiatric disorders; however, we include these small ncRNAs
because of their demonstrated ability for targeting gene silenc-
ing in a variety of contexts. Similar to miRNAs, siRNAs are
∼22 nt non-coding transcripts that are derived from natural anti-
sense transcripts, pseudogenes, and repetitive sequences within
endogenous dsRNA, as well as by an exogenous viral replication
mechanism that is able to initiate degradation of homologous
mRNAs (Sharp, 2001; Tam et al., 2008; Cech, 2011; Zhang et al.,
2012c). The biogenesis of siRNAs is similar to that of miRNA;
however, unlike the nuclear origin of miRNAs, they may originate
in both the cytoplasm and nucleus (Figure 1B; reviewed in Verdel
et al., 2009). This class of ncRNAs is associated with theAgo family
as well as the RISC complex, which transports the guide strand
to a target mRNA. Importantly, siRNAs show signiﬁcantly more
speciﬁc base pairing relative to miRNAs, and use Slicer activity
to cleave and degrade their target mRNAs (Valencia-Sanchez et al.,
2006). The speciﬁc base complement of exogenous siRNAs to viral
mRNAs, particularly in Drosophila and C. elegans, represents an
efﬁcient antiviral immune response (Wilkins et al., 2005; Umbach
and Cullen, 2009), whereas endogenous siRNAs are impor-
tant for controlling somatic transposable elements in Drosophila
(Chung et al., 2008) as well as in plants (Ito, 2011).
Perhaps the most striking quality of siRNAs is their synthetic
reproducibility, which makes them attractive tools to be used in
gene therapy for a variety of diseases. Theﬁrst successful attempt to
treat a human disease through RNAi-mediated gene silencing was
demonstrated with the use of siRNA against hepatitis C in mice
(Song et al., 2003). SiRNA has since emerged as the next “new class
of drugs” (Peer and Lieberman, 2011); however, several hurdles
must be overcome before siRNA-mediated gene therapy will make
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its way to the clinic. The primary issue is to effectively deliver
siRNAs without degradation by phagocytosis or the production of
off-target effects. A second concern is the design of membrane-
permeable siRNAs that readily cross the blood–brain barrier
(Dominska and Dykxhoorn, 2010). Advances in siRNA delivery
have begun to address these challenges through the development
of labeled magnetic nanoparticles, PEGylated LPD (liposome-
polycation-DNA), and cationic liposomes (Li et al., 2011). siRNA
has been successfully used to treat viral infections including polio,
human papilloma virus, echoviruses, and adenoviruses (Morris-
sey et al., 2005; Saulnier et al., 2006; Tan et al., 2007; Eckstein
et al., 2010). Furthermore, siRNAs have also been demonstrated
to be efﬁcacious in the treatment of human pancreatic can-
cer (Zhong et al., 2012), lung carcinoma (Podesta et al., 2009),
and ﬁbrodysplasia ossiﬁcans progressiva (Kaplan et al., 2011;
Takahashi et al., 2011).
Reports on the putative function of both endogenous and
exogenous siRNAs in the brain and their regulation of behavior are
emerging. Within the context of Parkinson’s disease, a neurode-
generative disease characterized by cognitive decline, Hommel
et al. (2003) found that siRNA-mediated knockdown of Th, which
is a gene responsible for the production of tyrosine hydroxylase
and a key enzyme within the dopaminergic pathway, attenu-
ated locomotor abnormalities in a mouse model of Parkinson’s
disease. Neuronal dysfunction due to mutations in the human
α-synuclein gene affect dopaminergic levels and have been asso-
ciated with idiopathic Parkinson’s disease as well as dementia
with Lewy bodies. Delivery of lentiviral-mediated siRNA has been
shown to effectively diminish endogenous expression of this gene
both in vitro and in vivo (Sapru et al., 2006). SiRNA designed
to target human Htt, a gene involved in Huntington’s disease,
which is also a neurodegenerative disorder characterized by cog-
nitive impairment, attenuates striatal neuropathology, and motor
deﬁcits in a mouse model of Huntington’s disease (Diﬁglia et al.,
2007). Moreover, these studies have been extended in both mice
and non-human primates, in which administration of siRNAs
selective for Huntingtin are effective in delaying neurodegener-
ation, and may also have some efﬁcacy in preventing the cognitive
decline observed in Huntington’s disease (Lombardi et al., 2009;
Pﬁster et al., 2009; Zhang et al., 2009; McBride et al., 2011;
Stiles et al., 2012).
It has been widely demonstrated that exogenous siRNA is also
a useful approach for inducing loss of function in studies inves-
tigating genes involved in synaptic plasticity, and learning and
memory. Early research found that siRNAs could be used to
silence endogenous and heterologous genes within the rat hip-
pocampus (Krichevsky and Kosik, 2002). The important role of
GluR1 in the acquisition and consolidation of spatial memory
has recently been demonstrated using siRNA (Das et al., 2012).
Interestingly, knockdown of CREB by siRNA has elucidated the
important role of O-GlcNAc-mediated glycolysation of CREB in
regulating dendritic outgrowth, a process critical for the forma-
tion of long-term memory (Rexach et al., 2012). Concordantly,
siRNA-mediated knockdown of the alpha 2 subunit of theGABAA
receptor within the amygdala decreases binge drinking, thereby
suggesting a potential role for endogenous siRNA in the regu-
lation of addiction-like behavior (Liu et al., 2011). Furthermore,
Panossian et al. (2012) employed an RNAi approach to demon-
strate the essential role of the stress hormone neuropeptide Y
(NPY ) in regulating the stress response.
Remarkably, the stability and turnover of both miRNA and
siRNA depend on the methylation status of their 3′ UTR,
which potentially protects these small RNAs from urydination
and exonucleolytic degradation (Ji and Chen, 2012; Zhao et al.,
2012).This observation supports the prospective role of endoge-
nous siRNAs, which is to control gene expression in mammalian
oocytes (Tam et al., 2008; Watanabe et al., 2008; Nejepinska et al.,
2012). These regulatory properties are also consistent with the
ﬁndings of Song et al. (2011) who identiﬁed endogenous siRNAs
in humans and mice, which are involved in developmental pro-
gramming of male germ cells. Even more exciting is the fact that
endogenous siRNAs may also direct transcriptional gene silencing
in the metazoan genome through the regulation of chromatin
modiﬁcation. For example, in C. elegans, Schizosaccharomyces
pombe, and Drosophila they direct H3K9 methylation to estab-
lish the formation of heterochromatin (Fagegaltier et al., 2009;
Burkhart et al., 2011).
Experience-dependent expression of endogenous siRNAs has
only recently been uncovered in the mammalian genome. For
instance, siRNA associated with genes involved in synaptic plas-
ticity are up-regulated in the hippocampus of mice subjected to
an olfactory discrimination paradigm (Smalheiser et al., 2010). As
mentioned, endogenous siRNAs aremostly derived from repetitive
elements in germinal tissues, thus supporting the hypothesis that
siRNAs might have evolved to sustain genomic stability during
early development. However, considering the remarkable ﬁnd-
ings of Smalheiser et al. (2011), who identiﬁed an endogenous
siRNA complementary to SynGAP1, and that dysregulation of
SynGAP1 correlates with mental retardation as well as autism
(Hamdan et al., 2009), these observations suggest a potentially
important role for endogenous siRNA in cognitive disorders.
Together, these early ﬁndings lay the foundation for the use
of siRNA-mediated gene knockdown as a therapeutic interven-
tion in a variety of disorders; however, it is not yet known
whether manipulation of siRNAs will be applicable to the clinical
treatment of cognitive deﬁcits associated with neuropsychiatric
disease.
PIWI-INTERACTING RNAs
P-element induced wimpy testis (PIWI)-interacting RNAs (PiR-
NAs) are the most distinct but least investigated of all the small
ncRNAs, and appear to function by repressing target gene expres-
sion within the nucleus instead of the cytoplasm (Saito et al.,
2006). They are associated with a subfamily of Ago proteins
containing an N-terminus called PAZ (from PIWI homologous
Argonaute and Zwillie) and a C-terminus PIWI domain (Parker
et al., 2005). PIWI proteins are highly abundant in the germline,
and play an essential role in normal gonadal development in
mice, with mutations resulting in male infertility (Cox et al.,
1998; Girard et al., 2006; Klattenhoff and Theurkauf, 2008; Beyret
and Lin, 2011). In 2001, Aravin et al. discovered a novel small
ncRNA involved in the silencing of the testis-expressed Stel-
late gene in Drosophila but they did not realize that they were
looking at PIWI protein interacting RNAs (Aravin et al., 2001;
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Siomi et al., 2011). Later,Watanabe et al. (2006) revealed the exis-
tence of mouse germline small RNAs between ∼26 and ∼30 nt
long, which they named gsRNAs. Although these investigators
veriﬁed an expression pattern that correlated with MIWI and
MILI, two members of the PIWI protein family, they did not
uncover the extent of the association and the true nature of the
piRNAs. This connection was later made in mice where it was
discovered that MILI and MIWI murine PIWI proteins bind,
respectively, to 26 and 30 nt RNAs, which subsequently became
known as piRNAs (Aravin et al., 2006; Girard et al., 2006; Grivna
et al., 2006). Soon after, piRNAs were found in rat testes (Lau
et al., 2006) as well as in Drosophila where they induced silencing
of the Suppressor of Stellate locus found on the Y chromosome
(Vagin et al., 2006).
Although it was initially suggested that piRNAs are only
expressed in germinal cells (Carmell et al., 2007; Grimson et al.,
2008; Beyret and Lin, 2011), they are also found in somatic tissue
(Malone et al., 2009; Lee et al., 2011; Yan et al., 2011; Rajasethupa-
thy et al., 2012). PiRNAs elude cleavage by Dicer and Drosha and
are mostly derived from repetitive elements called piRNA clusters
(Aravin et al., 2006; Girard et al., 2006; Grivna et al., 2006; Saito
et al., 2006; Brennecke et al., 2007; Malone et al., 2009; Malone and
Hannon, 2009). Although these clusters retain interspecies conser-
vation, piRNA sequences themselves show no evolutionary con-
servation (Aravin et al., 2006; Girard et al., 2006; Lau et al., 2006).
This interesting characteristic suggests a locus-speciﬁc function of
piRNAs whereby they inhibit only those transcripts derived from
the genomic region in which they originate (Lau et al., 2006).
PiRNAs can also be derived from the 3′ UTR of protein-coding
genes and euchromatic transposable elements (Muerdter et al.,
2012), as well as from non-repetitive genomic DNA (Kim et al.,
2008). In addition, through the insertion and transcription of an
exogenous sequencewithin an endogenous piRNAcluster locus,de
novo piRNAs can be produced fromnon-repetitive protein-coding
sequences (Kawaoka et al., 2012). This revelation paves the way for
the exploration of the role of piRNAs in the regulation of protein-
coding genes through sequence-speciﬁc recognition and a Dicer-
independent siRNA pathway, perhaps by using PIWI nuclease
activity.
PiRNAs are transcribed through two well-described mecha-
nisms (Figure 2). The so called “ping pong” pathway is mainly
observed in the cytoplasm of germ cells where pre-piRNAs derived
from transposons are cleaved by unknown nucleases and form a
complex with MILI proteins to direct MILI slicer activity against
target mRNAs. This step results in a new secondary piRNA. The
secondary piRNA is then coupled to a MIWI2 protein, which in
turn exhibits endonuclease activity on theopposite strand andpro-
duces a new pre-piRNA, which again forms a complex with MILI
in an ampliﬁcation loop (Brennecke et al., 2007; Kim et al., 2009;
Siomi et al., 2011; Pillai andChuma,2012). TheMIWI2 interacting
piRNA is also transported back to the nucleus where it represses
transposable elements through the regulation of DNAmethylation
(Aravin and Bourc’his, 2008; Aravin et al., 2008; Kuramochi-
Miyagawa et al., 2008; Watanabe et al., 2011). A modiﬁcation
may occur where pre-piRNAs are associated with MIWI proteins
instead of MILI and generate a secondary piRNA that appears to
remain in the cytoplasm and drives the “primary pathway,” which
is present in somatic cells (Kim et al., 2009; Siomi et al., 2011;
Pillai and Chuma, 2012).
Remarkably, piRNAs exploit DNA methylation and chromatin
remodeling to serve their regulatory function in mammals. Muta-
tions induced in murine MILI result in a loss of DNAmethylation
and a consequent up-regulation of long interspersed element-1
(LINE-1) and IAP (intracisternal A particle) elements (Aravin
et al.,2007). Similarly,MIWI2mutants also show increased expres-
sion of LINE-1 and IAP repetitive sequences, which correlate
with higher DNA demethylation levels in the testes (Carmell
et al., 2007). Initially, co-immunoprecipitation studies of MIWI2
failed to demonstrate a direct interaction with DNMT3a and
DNMT3b, suggesting that PiRNAs do not directly regulate the
activity of these enzymes (Aravin et al., 2008). However, additional
investigations have shown impaired de novo DNA methylation
and decreased piRNA levels in germline cells derived from MILI
knockout mice, thus verifying a role for MILI-bound piRNAs
in timing the methylation of transposons (Kuramochi-Miyagawa
et al., 2008). Interestingly, Watanabe et al. (2011) proposed that
piRNAs may interact with other small ncRNAs transcribed from
differentially methylated genomic regions in order to drive de
novo methylation of the locus corresponding to the associated
ncRNA. PiRNAs seem to also participate in chromatin remod-
eling processes by recruiting major chromatin modiﬁers. These
piRNAs, identiﬁed as piALU RNAs, have been shown to regu-
late chromatin organization within and around centromeres as
well as by directing mechanisms of DNA repair and transcription
(Blackwell et al., 2012).
Although the main role of piRNAs appears to be in the
maintenance of genomic integrity and DNA stability through
epigenetic silencing of transposable elements during early devel-
opment (Vagin et al., 2006; Aravin et al., 2007; Brennecke et al.,
2007; O’Donnell and Boeke, 2007; Dharap et al., 2011), the identi-
ﬁcation of ischemia-responsive piRNAs in the cortex of the adult
rat (Dharap et al., 2011) suggests an important role for piRNAs
across the lifespan. The recent demonstration that intergenic
piRNAs are expressed in the mouse hippocampus, particularly
within the dendritic compartment, indicates that piRNAs are
functionally active in the adult central nervous system (CNS).
Knockdown of piRNA QD541777 in hippocampal neurons leads
to a decreased number of dendritic spines potentially via the reg-
ulation of mRNA derived from Cdk5rap1 andMark 1/2, two genes
with active roles in CNS development (Lee et al., 2011). More-
over, a cluster of four piRNAs was also found to be associated
with other genes involved in dendrite formation and neuronal
migration (Lee et al., 2011). Consistent with these ﬁndings, Kandel
and colleagues recently discovered neuronally expressed piRNAs
that promote DNA methylation of the CREB2 promoter thereby
facilitating synaptic plasticity in Aplysia (Rajasethupathy et al.,
2012). These ﬁndings suggest a potential role for piRNAs in tran-
scriptional gene silencing and in the epigenetic facilitation of
long-term memory.
Interestingly, the TUDORprotein interacts with PIWI proteins,
and consequently with piRNAs, in coordinating the regulation of
LINE-1 retrotransposon activity (Chen et al., 2009; Reuter et al.,
2009; Siomi et al., 2010; Yabuta et al., 2011). Together with the fact
that LINE-1 inﬂuences experience-dependent neuronal plasticity
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FIGURE 2 | Primary single-stranded intergenic piRNAs are transcribed
within the nucleus from well-conserved clusters of repetitive elements.
Once in the cytoplasm they either interact with MIWI proteins and initiate the
“primary pathway,” or directly with MILI proteins to trigger the “ping-pong
cycle.” PiRNAs associated with MILI direct its slicer activity against target
mRNAs, thereby producing a secondary piRNA, which is then coupled to
MIWI2. MIWI2 piRNA can return to the nucleus where it targets repetitive
elements, or remains within the cytoplasm where it exerts endonuclease
activity on the opposite strand to reproduce a new pre-piRNA that interacts
with MILI in a self-ampliﬁcation loop.
and somatic mosaicism within the hippocampus (Coufal et al.,
2009;Muotri et al.,2009;Muotri et al.,2010), one can envisionhow
the activity of piRNAs might be integral to these processes. It is
remarkable that the current focus on the role of piRNAs is limited
to the silencing of transposable elements in early development
when in fact they may be potent regulators of neural plasticity and
cognitive function.
LONG ncRNAs
Long ncRNAs are transcripts over 200 nt long that can be found
in both the cytoplasm and the nucleus where they exhibit tightly
regulated spatiotemporal patterns of expression (Kapranov et al.,
2007; Guttman et al., 2009; Khalil et al., 2009). Initially, long
ncRNAs were believed to be the least conserved of all ncRNAs
and to mainly serve as precursors for small RNAs (Kapranov et al.,
2007). Their low level of expression also fueled the debate that
they might merely be the result of transcriptional noise or arti-
facts of high-throughput sequencing (Struhl,2007;VanBakel et al.,
2010). However, it has been shown that some long intergenicRNAs
are under purifying selection in mammals (Ponjavic et al., 2007;
Guttmanet al.,2009) and exhibit cross-species conservation aswell
as function-speciﬁc stability (Marques and Ponting, 2009; Ulitsky
et al., 2011; Clark et al., 2012). Interestingly, nuclear long ncRNAs
undergo a high rate of turnover and are relatively unstable, which
is concordant with the notion that they provide a mechanism for
rapid response to external stimuli (Mercer et al., 2009; Clark et al.,
2012). Due to these characteristics, long ncRNAs appear to be in
a state of constant and rapid evolutionary development. However,
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short sequences nested within long ncRNAs, particularly those
close to the promoter region, are highly conserved (Ponjavic et al.,
2007; Guttman et al., 2010; Ulitsky et al., 2011),which suggests that
theymight represent coremotifs forRNAbinding proteins respon-
sible for the extensive chromatin remodeling functions attributed
to a variety of long ncRNAs. This would support the idea that it is
the function of long ncRNAs in relation to protein-coding genes,
and not their primary sequence, that is critical for their inﬂuence
on gene expression and positions long ncRNAs as ﬂexiblemodular
scaffolds (Guttman and Rinn, 2012).
Although, the precise biogenic pathway of long ncRNAs is not
yet fully understood, it involvesRNAPol II-mediated transcription,
polyadenylation, and end-capping (Guttman et al., 2009). Long
ncRNAs are derived from sense and antisense strands, intergenic
and intronic regions, and overlapping regions of protein-coding
genes. Furthermore, novel subsets of long ncRNAs called macro-
RNAs are believed to serve as precursors for other small and long
non-coding transcripts (Furuno et al., 2006). These might origi-
nate via de novo transcription of precursor non-coding transcripts,
by duplication of another ncRNA or by loss of function of an
ancestral protein-coding gene (Ulitsky et al., 2011). An interesting
example of a long ncRNA derived from a former protein-coding
sequence isXist, whichhas arisen from themutatedprotein-coding
gene, Lnx3 (Duret et al., 2006). Moreover, Tsx is a long ncRNA
derived from the loss of protein-coding function within the same
locus (Anguera et al., 2011). It has also been proposed that long
ncRNAs originate from genomic sequences from exonic regions,
from chromosome rearrangement, or by duplication of the non-
coding gene through retrotransposition activity and insertion of
transposable elements (Ponting et al., 2009).
Long ncRNAs may function as enhancers as well as repres-
sors through coordinated regulation of epigenetic processes, both
in cis and in trans, as illustrated in Figure 2 (Khalil et al., 2009;
Orom et al., 2010a,b; Guttman et al., 2011). Considering that
they account for the majority of the non-coding transcriptome
(Mattick and Makunin, 2006; Jia et al., 2010), that 20% of long
ncRNAs found in the human genome are bound to the poly-
comb group protein repressive complex (PRC), and that more
than 50% of all known long ncRNAs interact with other chro-
matin modifying complexes such as CoREST and SMCX (Khalil
et al., 2009), they are likely to be heavily involved in the epigenetic
regulation of neural plasticity. Prototypical examples of epigenetic
regulation directed by long ncRNAs include chromatin remodel-
ing by Xist, acting in cis, to drive X chromosome inactivation
(Duret et al., 2006), andHOTAIR, operating in trans, to silence the
HOXD locus by recruitment of PRC2 (Rinn et al., 2007). Their
role in imprinting is also evident in the activity of the pater-
nally expressed lncRNA, Air, which directs silencing of IGF2R,
Slc22a2, and Slc22a3, through the recruitment of G9a histone
methyltransferase and methylation of H3K9 domains (Nagano
et al., 2008). Another example of a long ncRNA that induces chro-
matin remodeling involves Kcnq1ot1, which interacts with Dnmt1
to regulatemethylation of theKcnq1 gene through the recruitment
of thehistonemethyltransferasesEzh2 andG9a (Mohammadet al.,
2010, 2008; Pandey et al., 2008). Each of the examples further
emphasizes the important role of long ncRNAs in directing epi-
genetic processes. Given the emerging appreciation for epigenetic
mechanisms in learning and memory (Day and Sweatt, 2010), an
understanding of how long ncRNAs direct the epigenome within
the context of neural plasticity, cognition, and neuropsychiatric
disorders is on the horizon.
Long ncRNAs have already been associated with several neu-
rodegenerative disorders characterized by impaired cognitive
function. For instance, along ncRNA isoform of the overlapping
SOX2 gene transcript called SOX2OT regulates CNS vertebrate
development, as well as neurogenesis in adult mice (Amaral et al.,
2009), and thus represents a candidate biomarker for Alzheimer’s
disease (Arisi et al., 2011). Furthermore, the novel long ncRNA17A
directs the splicing of GPR51, thereby producing an alterna-
tive GABAB receptor isoform, which results in a signiﬁcant
impairment in GABAB receptor signaling in Alzheimer’s disease
(Massone et al., 2011). An additional example of the versatility
of long ncRNAs in driving gene expression within the human
brain is the BACE1 antisense transcript, which prevents miR-485-
5p induced expression of BCAE1 gene by competing for the same
binding site on its mRNA. Indeed, dysregulation of this long
ncRNA has also been reported in Alzheimer’s disease (Faghihi
et al., 2010). Disruption of key long ncRNAs may also play a role
in the development of psychiatric disorders. For example, the
long ncRNA disrupted in schizophrenia 2 (DISC2), is antisense to,
and overlaps with, its protein-coding transcript DISC1. This long
ncRNA has been implicated in schizophrenia, bipolar depression,
and autism spectrum disorder (Millar et al., 2000; Chubb et al.,
2008; Williams et al., 2009).
It is becoming clear that long ncRNAs have a direct role in
the regulation of genes involved in neural plasticity and cogni-
tive function. For example, BDNF supports neuronal survival and
synaptic plasticity and is critically involved in learning and mem-
ory (Hall et al., 2000; Rattiner et al., 2004a,b; Bredy et al., 2007).
A human antisense transcript called BDNFOS or antiBDNF was
previously shown to interact with its sensemRNA,BDNF (Pruun-
sild et al., 2007). Interestingly, very recently a conserved antisense
transcript to BDNF has been discovered in mice, which inhibits
BDNF transcription by recruitment of EZH2, a key component
of the epigenetic silencing complex, PRC2. Additionally, admin-
istration of a sequence-speciﬁc inhibitor called an antagoNAT
or siRNA-mediated knockdown of BDNF-AS both lead toup-
regulation of BDNF mRNA and protein expression in vitro and
in vivo, resulting in increased neurite outgrowth and maturation
(Modarresi et al., 2012).
The potential importance of long ncRNA activity related to
higher order cognitive processing is also highlighted by the discov-
ery of human accelerated region 1 (HAR1F), which is expressed
in Cajal–Retzius neurons and was one of the ﬁrst long ncRNAs
shown to be involved in human neocortical development (Pollard
et al., 2006). Recently it was found that repression of HAR1F by
REST leads to its decreased expression in the striatum of Hunting-
ton’s disease (Johnson et al., 2010), and that REST also interacts
with DGCR5 and TUG1 lncRNAs leading to DiGeorge syndrome
and Huntington’s disease (Johnson et al., 2009; Johnson, 2011).
Johnson (2012) extended these investigations and conﬁrmed that
both TUG1 andNEAT1 are signiﬁcantly up-regulated in Hunting-
ton’s disease brains, whereasMEG3 andDGCR5 showed decreased
expression.
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Among other functions, the organization of the nuclear archi-
tecture also seems to require the transcription of the polyadeny-
lated long ncRNA NEAT1, which is associated with nuclear
paraspeckles (Clemson et al., 2009; Souquere et al., 2010), and
NEAT2 (also known asMALAT1 –metastasis-associated lung ade-
nocarcinoma transcript 1), which regulates synapse formation
(Bernard et al., 2010). Furthermore, the long ncRNA Cycling D1
(CCND1) interacting with a protein called translocated in liposar-
coma (TLS; as indicated in Figure 3), acts as a transcriptional
co-repressor and as a sensor of DNA damage by binding and
repressing both CREB and p300 acetyltransferase leading to the
silencing of their target gene (Wang et al., 2008a). Given the impor-
tant role of CREB and p300 in regulating neural plasticity and
cognitive function, it would be interesting to determine whether a
disruption of the long ncRNA CCND1 can cause impairments in
cognitive function similar to those observed when either CREB or
p300 is inhibited.
The ability of long ncRNAs to interact with transcription fac-
tors also endows them with a remarkable capacity to orchestrate
mammalian neurogenesis, which will undoubtedly have an inﬂu-
ence on cognition. For example, the long non-coding transcript
Evf2, derived from the Dlx5/6 gene locus, binds to the home-
odomain ofDlx-2 forming an enhancer-like complex that activates
Dlx5/6 expression (as described in Figure 3; Feng et al., 2006).
The relevance of this long ncRNA in the hippocampus and cogni-
tion is exempliﬁed through studies on Evf2 knockout mice, which
exhibit impaired synaptic plasticity and spatial memory as a result
of aberrant interneuron development (Bond et al., 2009). Extend-
ing these discoveries, Ng et al. (2012) have demonstrated that long
ncRNAs interact with transcription factor SOX2 as well as PRC2,
with the authors suggesting that they are required for pluripo-
tency of neural progenitor cells. Additionally, long ncRNAs have
been shown to direct that activity of other ncRNAs within the
CNS. Indeed, the cytoplasmic long ncRNA, lncRNA_N2, harbor-
ing miRNA miR-125B, regulates the transcription of this small
RNA and indirectly promotes neurogenesis.
More excitingly, long ncRNAs have also been associated with
drug addiction and, potentially, fear-related anxiety disorder.
For instance, the long ncRNAs MIAT, MEG3, and NEAT1/2 are
up-regulated within the nucleus accumbens of heroin abusers
(Michelhaugh et al., 2011). Accordingly, a previous genome-wide
association study has implicated MEG3 with potential predisposi-
tion to heroin addiction (Nielsen et al., 2008). Interestingly,MIAT
is associated with the nuclear matrix and is involved in oligo-
dendrocyte development (Mercer et al., 2010), whereas MEG3
is a cAMP-responsive, maternally imprinted, long ncRNA that
is expressed in distinct subpopulations of neurons (Zhao et al.,
2006; Michelhaugh et al., 2011) and contributes to early neuro-
genesis (Mercer et al., 2010). More recently, the lncRNA RMST,
also known as dorsomedial telencephalon gene 2 (DMT2), was
revealed to interact with nuclear and chromatin factors dur-
ing the development of dopaminergic neurons (Ng et al., 2012).
Additionally, the long ncRNA BC1 has been shown to direct the
activity of the dopamine 2 receptor (Drd2) as well as metabotropic
FIGURE 3 | (A) Upon receiving a signal for DNA damage, the long ncRNA
CCND1 binds to theTLS protein to direct a protein complex to the CCND1
target gene where allosteric modiﬁcation of CREB and the histone
acetyltranserases (HATs) CBP and p300 are produced, which results in
gene silencing. (B) Long ncRNA Evf2 is transcribed from an ultra conserved
intergenic region within the Dlx-5/6 locus. Binding of this long ncRNA to the
Dlx-2 protein triggers transcriptional activation of the Dlx-5/6 enhancer region
in a homeodomain-speciﬁc manner.
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glutamate receptors (mGluR), which are required for balancing
neuronal excitability at the synapse (Zhong et al., 2009), and that
BC1−/−mice develop increased anxiety (Centonze et al., 2007).
Considering the important role of Drd2 andmGluRs in regulating
the extinction of conditioned fear, it is possible that a dysregula-
tion of the long ncRNA BC1 contributes to the development of
fear related anxiety disorders.
Through their interaction with various epigenetic regulatory
proteins, long ncRNAs might serve as molecular brakes on tran-
scriptional activity, as originally proposed by McQuown and
Wood (2011) within the context of HDAC activity and memory
formation, which in our opinion would also contribute greatly
to rapid, experience-dependent, variations in genomic function.
Consequently, it is anticipated that long ncRNAs will have pro-
found effects on neural plasticity and cognition associated with
neuropsychiatric disorders. In summary, cell type-speciﬁc pat-
terns of long ncRNA expression may serve to coordinate the
ﬁdelity of synaptic plasticity and neural connectivity by dynam-
ically monitoring and integrating multiple transcriptional and
post-transcriptional events (Mercer et al., 2008; Qureshi and
Mehler, 2011).
Finally, as described inTable 1, there are alsomany other classes
of ncRNAs not discussed in this review, the understanding of
which is only starting to emerge.
Table 1 | Identification and known characteristics of other ncRNAs.
NcRNA Size Characteristics Reference
eRNAs ∼100 bp to 91 kb Show homologous chromatin modiﬁcations to protein coding genes, aid in
enhancement of non-speciﬁc cell neighboring genes expression. A subtype
identiﬁed in mouse neuronal cells shows association with enhancers and
positive correlation with their levels of mRNA synthesis
Kim et al. (2010),
Orom et al. (2010a,b)
TERRAs 100 bp to 9 kb Conserved in mammals localized in the nucleoplasm in all mammalian
chromosomes at telomeric regions of interphase and metaphase cells.
RNA Pol II and developmental stage Dependant. Potentially involved in
eukaryotic heterochromatin conformation, telomere length and function in
human iPS cells and regulation of telomerase activity
Azzalin et al. (2007),
Schoeftner and Blasco (2008),
Deng et al. (2009),
Luke and Lingner (2009),
Redon et al. (2010),
Yehezkel et al. (2011)
tel-sRNAs ∼24 bp Evolutionary conserved, potential involvement in telomere structure and function,
suggested to be regulated by epigenetic mechanisms
Cao et al. (2009)
TASRs 20–200 bp Clustering at the 3′ end. Conserved in mouse and human genomes with yet
undescribed functions but potential role in gene expression suggested
Kapranov et al. (2007),
Carninci et al. (2008),
Zhang et al. (2012a)
aTASRs Unspeciﬁed 5′ poly U short RNAs antisense to 3′ ends of annotated regions undetermined
functionality.
Kapranov et al. (2010)
PASRs 26–50 bp Mapped within 500 nt of knownTSS. Mostly overlapping with 5′ end of protein
coding genes. Association with RNA Pol II, Histone H3 and H4 acetylation and
potential up regulation of neighboring genes
Kapranov et al. (2007), Carninci
et al. (2008), ENCODE
Transcriptome Project (2009)
PALRs 200 bp to 1 kb Overlapping with 5′ end of protein coding genes. Potential up regulation of protein
coding genes showing evolutionary conserved sequences
Kapranov et al. (2007)
PROMPTs ∼200–600 bp Transcribed from upstream regions of annotatedTSSs, they are polyadenylated,
highly unstable and mostly restricted to the nucleus. Suggested to affect
promoter methylation and regulate transcriptional processes
Preker et al. (2008, 2011)
TiRNAs ∼15 to 30 bp Enriched in the nucleus, transcribed from downstream ofTSS sequences are linked
to CpG rich promoters, transcription factor binding, and widespread transcription
initiation inducing up regulation of protein coding genes
Taft et al. (2009, 2010)
Stress-tiRNAs Unspeciﬁed 5′ and 3′ end small-derived RNAs from tRNAs are induced to inhibit translation as a
stress response pathway
Emara et al. (2010)
spliRNAs ∼18 bp Developmental stage and region speciﬁc expression, Dicer and Drosha
independent pathways.Weakly expressed, associated with highly expressed loci
(Taft et al., 2010)
moRNAs ∼20 bp Processed by nuclear Drosha, 5′ derived transcripts from of miRNAs precursors,
weakly expressed and with unknown functions
Langenberger et al. (2009),
Taft et al. (2010)
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Although the biogenesis of most of these non-coding tran-
scripts remains unclear, their tissue-speciﬁcity and developmental
stage-dependent expression provides strong evidence for their
biological relevance justifying the need for further research into
the complex regulatory potential hidden within the eukaryotic
transcriptome.
OUTLOOK AND CONCLUSION
The huge repertoire of ncRNAs, that we are only beginning to
recognize, suggests a sophisticated RNA-mediated layer of control
over genomic function that has evolved to coordinate tissue- and
developmental stage-speciﬁc regulation of gene expression. The
redundancy in consensus sequences typical of most ncRNAs allows
for a highly efﬁcient transcriptional regulation of protein-coding
genes, whereas the potential stability provided by the methyla-
tion status of most small ncRNAs supports their well established
role in regulating gene expression. In the case of some long ncR-
NAs, their low level of conservation may contribute directly to
their function by enabling the cell to respond to external stim-
uli with greater ﬂexibility, thereby conferring a rapidly adaptive
plasticity that is distinct from, and more complex than, the much
slower acting protein-coding genes (Mattick, 2011). Consequently
and given that ncRNAs are highly expressed in the brain, it is
anticipated that they will play a signiﬁcant role in driving neu-
ral connectivity within learning and behavioral adaptation of
higher eukaryotes. This ﬁrmly positions ncRNAs at the fore-
front of cell-to-cell communicationwithin the context of cognitive
function and potentially in the development of neuropsychi-
atric disorders. Given that a signiﬁcant proportion of known
long ncRNAs interact with repressive complexes, future investi-
gations will expand on these observations through the application
of innovative techniques including high-throughput sequencing
together with UV-crosslinking and immunoprecipitation (HITS-
CLIP; Zhang and Darnell, 2011), chromatin isolation by RNA
puriﬁcation (ChIRP; Chu et al., 2011), capture hybridization anal-
ysis of RNA combined with RNA sequencing (CHART; Simon
et al., 2011), and RNA-capture-Seq (Mercer et al., 2011). Such
studies will aid in the determination of novel ncRNAs and their
genome-wide binding sites, which will be important to elucidate
the essential role of RNA-directed epigenetic regulation of gene
function. Most studies on ncRNAs have been based on stem cell
and embryonic development, with the function of miRNAs in the
adult brain only recently becoming appreciated. Moreover, in vitro
studies examining long ncRNAs and piRNAs, and their inﬂuence
on neural plasticity, are emerging. It will be exciting to see how
these in vitro ﬁndings translate in vivo and to elucidate whether
the biological signiﬁcance of these ncRNAs will extend to mem-
ory and cognition. Furthermore, RNAi will be a useful tool to
facilitate the knockdown of ncRNAs that are associated to neu-
ropsychiatric disorders, such as TUG1 and NEAT1. Consequently,
if lncRNAs truly representmodular scaffolds, then it will be imper-
ative to determine the stability of the epigenetic processes directed
by all classes of ncRNAs, particularly those resulting from rapidly
changing behavioral responses. Given the fact that endogenous
siRNAs are mostly represented in oocytes, whereas piRNAs are
strongly expressed in the male germ line, each capable of exerting
their owngenomic function, alsomakes themattractive candidates
to investigate their potential inﬂuence on genomic imprinting
and transgenerational epigenetic inheritance. Finally, since many
ncRNAs remain transcriptionally quiescent until a speciﬁc devel-
opmental stage is met or an appropriate environmental signal is
received (Kretz et al., 2012), it will be important to decipher the
mechanisms coordinating such precise and rapid genomic respon-
siveness. The central dogma of protein-coding genes controlling
the eukaryotic genome represents an archaic constraint on our
journey to truly expand the understanding of gene–epigenome–
environmental interactions. It is undeniable that this layer of gene
regulation has many fundamental biological and functional roles
yet to be explained and it might be within neural plasticity, cog-
nition, and neuropsychiatric disorders where the lasting signature
of ncRNAs could be at their most signiﬁcant.
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